Targeting of High Peak Respiratory Exchange Ratio Is Safe and Enhances the Prognostic Power of Peak Oxygen Uptake for Heart Failure Patients

  • Nakanishi Michio
    Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
  • Takaki Hiroshi
    Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center Research Institute
  • Kumasaka Reon
    Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
  • Arakawa Tetsuo
    Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
  • Noguchi Teruo
    Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
  • Sugimachi Masaru
    Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center Research Institute
  • Goto Yoichi
    Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center

この論文をさがす

抄録

Background:Peak oxygen uptake (V̇O2) and ventilatory efficiency (V̇E/V̇CO2slope) measured on cardiopulmonary exercise testing (CPX) are prognostic indicators in heart failure (HF) patients, but peak V̇O2is influenced by patient effort. In CPX targeting a peak respiratory exchange ratio (pRER; an objective index of effort adequacy) higher than the commonly recommended level, we assessed the safety and prognostic value of CPX parameters compared with non-CPX parameters.Methods and Results:We studied 283 consecutive HF patients with left ventricular ejection fraction (LVEF) ≤45% (mean, 26.3%) who underwent CPX targeting pRER >1.20. The attained pRER (mean, 1.26) was consistently high irrespective of LVEF, and there was no major exercise-related adverse event. The composite of all-cause death or HF hospitalization occurred in 111 patients (39%) during a median follow-up of 47 months. Among well-known prognostic markers, peak V̇O2was the most powerful predictor of outcome as both a continuous and an optimal dichotomous variable, followed by V̇E/V̇CO2slope. On multivariate analysis, peak V̇O2was a significant independent predictor, whereas V̇E/V̇CO2slope, B-type natriuretic peptide, and LVEF were not.Conclusions:In CPX targeting pRER >1.20 for HF patients, peak V̇O2is the most powerful among well-known predictors, without an increased risk of exercise-related events. These findings advocate a high target pRER in CPX even in advanced HF. (Circ J 2014; 78: 2268–2275)

収録刊行物

  • Circulation Journal

    Circulation Journal 78 (9), 2268-2275, 2014

    一般社団法人 日本循環器学会

被引用文献 (15)*注記

もっと見る

参考文献 (31)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ